Stocktoria
SIGA TECHNOLOGIES INC SIGA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1997-09-09
SIGA TECHNOLOGIES INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $94.6M | $138.7M | $139.9M | $110.8M | $133.7M | $125.0M | $26.7M | $477.1M | $12.3M | $15.0M |
| R&D expense | $20.0M | $12.3M | $16.4M | $22.5M | $9.9M | $10.9M | $13.3M | $13.0M | $16.7M | $19.7M |
| SG&A expense | $21.2M | $25.1M | $22.0M | $35.1M | $18.0M | $14.7M | $13.3M | $12.9M | $12.3M | $13.7M |
| Operating income | $23.7M | $70.0M | $83.6M | $42.7M | $89.1M | $84.5M | -$2.3M | $355.1M | -$18.8M | -$31.0M |
| Interest expense | — | — | — | $0 | $0 | $3.0M | $15.8M | $15.5M | $14.8M | $2.4M |
| Income tax | $7.1M | $16.9M | $19.7M | $10.2M | $19.9M | $17.2M | -$2.9M | -$10.2M | -$2.1M | $13,884 |
| Net income | $23.3M | $59.2M | $68.1M | $33.9M | $69.5M | $56.3M | -$7.2M | $421.8M | -$36.2M | -$39.7M |
| EPS (diluted) | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 | $0.71 | $-0.15 | $5.18 | $-0.46 | $-0.69 |
| Operating cash flow | $43.5M | $48.8M | $94.8M | $41.6M | $11.5M | $71.5M | -$18.2M | $68.9M | -$18.4M | -$116.8M |
| Free cash flow | — | — | — | — | — | — | -$18.2M | $68.8M | -$18.5M | -$116.8M |
| Cash & equivalents | $155.0M | $155.4M | $150.1M | $98.8M | $103.1M | $117.9M | $65.2M | $100.7M | $19.9M | $28.7M |
| Inventory | $49.1M | $49.6M | $64.2M | $39.3M | $19.5M | $20.3M | $9.7M | $2.9M | $3.0M | $26.2M |
| Total assets | $219.5M | $244.3M | $254.4M | $195.0M | $214.7M | $149.8M | $198.6M | $203.4M | $144.7M | $161.0M |
| Total liabilities | $20.6M | $28.5M | $57.5M | $24.9M | $40.4M | $20.0M | $100.8M | $100.5M | $467.8M | $448.4M |
| Shareholders' equity | $198.8M | $215.8M | $196.9M | $170.2M | $174.3M | $129.8M | $97.8M | $102.9M | -$323.1M | -$287.4M |
Growth · year-over-year · Revenue CAGR 22.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -31.8% | -0.9% | +26.3% | -17.1% | +7.0% | +367.3% | -94.4% | +3788.3% | -18.1% | — |
| Net income growth | -60.7% | -13.0% | +100.8% | -51.2% | +23.3% | — | -101.7% | — | — | — |
| EPS growth | -61.0% | -13.7% | +106.5% | -49.5% | +28.2% | — | -102.9% | — | — | — |
| Free cash flow growth | — | — | — | — | — | — | -126.5% | — | — | -1162.1% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.